HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)

Inclusion Criteria: * Men and women 18 to 65 years of age, inclusive * Inactive CHB with documented HBsAg positivity for at least 12 months before Day 1 * qHBsAg ≥ 10 IU/mL but ≤ 100 IU/mL in the 12 months prior to screening * HBV DNA ≥ 10 IU/mL at screening * AST, ALT, INR, albumin, total bilirubin (excluding patients with Gilbert Syndrome) and direct bilirubin within normal limits at screening Exclusion Criteria: * Positive hepatitis B e antigen (HBeAg) at screening * History of a hepatitis B flare or 1-log increase in HBV DNA or HBsAg in the prior 12 months * Undetectable HBV DNA at screening * Fibroscan \> 8.5 kPA at screening, or history of hepatic fibrosis or cirrhosis (NB, a Fibroscan is not required if an examination is performed within 12 months or a liver biopsy was performed within 2 years before Screening and no fibrosis \[F1 or greater\] was identified).